AIIMS New Delhi and ISRO sign historic MoU to pioneer space medicine research, studying zero-gravity human physiology for Gaganyaan missions while unlocking Earth healthcare breakthroughs.
Glimpse:
Dr. M Srinivas and Dinesh Kumar Singh lead partnership targeting microgravity bone loss, radiation effects, and astronaut mental health – positioning India as 4th global space medicine power.
AIIMS Director Dr. M Srinivas and ISRO Human Space Flight Centre Director Dinesh Kumar Singh signed landmark agreement on March 10, 2026, witnessed by ISRO Chairman Dr. V Narayanan.
This powerhouse collaboration fuses AIIMS clinical research expertise with ISRO mission data to conquer zero-gravity health threats – 1-2% monthly bone loss, 20% muscle degradation, cardiovascular deconditioning, radiation immunity suppression, and isolation brain effects.
The partnership powers Gaganyaan India’s first manned mission through comprehensive medical protocols across pre-flight conditioning, in-flight monitoring, and post-mission recovery. 300+ physiological parameters ensure astronaut safety while generating data for earthly applications.
Earth benefits massive: osteoporosis drugs from bone studies, cancer therapies from radiation research, Alzheimer’s protocols from brain isolation data, cardiac wearables from heart research. 300 hospitals adopt space diagnostics within 5 years.
Timeline targets Q2 2026 research activation, 2027 microgravity experiments, 2028 Gaganyaan clearance, 2030 space tourism standards. India joins NASA/ESA/Roscosmos elite.
"This catapults India into space medicine leadership. Viksit Bharat healthcare reaches orbit by 2047!"
By
HB Team
Related News
